Earnings
-
Pear, tight on cash, considers strategic alternatives
The digital therapeutics firm is considering a sale, merger, divestiture, licensing, or seeking additional financing.
By Elise Reuter • March 17, 2023 -
Senseonics grows sales in Q4 despite ‘softer demand’ for CGM implant in US and Germany
Demand in the U.S. was affected by “a little bit of ambiguity on pricing” ahead of a change to Medicare.
By Nick Paul Taylor • March 17, 2023 -
iRhythm beats Q4 expectations, shares rise on Zio XT account openings
Progress on addressing operational issues, along with increased Zio sales, drove revenue growth, analysts said.
By Susan Kelly • Feb. 24, 2023 -
Insulet exceeds sales forecast amid signs Omnipod 5 is winning share in diabetes pump market
The pump will be a “share taker for some time to come,” as patients switch from rival devices, said Insulet’s CFO.
By Nick Paul Taylor • Feb. 24, 2023 -
Tandem sees growth in new product launches after $95M loss on decline in pump placements
Craig Hallum analysts said 2022 was a “tough year” for Tandem but noted the company’s 2023 forecast should “properly” set expectations.
By Elise Reuter • Feb. 23, 2023 -
Globus’ full-year sales top $1B as analysts continue to question wisdom of NuVasive takeover
Analysts raised concerns about Globus’ planned $3.1 billion takeover of spine specialist NuVasive, asking about the company’s “flexibility and willingness to close the deal.”
By Nick Paul Taylor • Feb. 23, 2023 -
Smith+Nephew posted underlying sales growth in Q4; profit slides
The company has made progress with product availability even as it still faces supply chain issues with semiconductors, resins and sterilization capacity.
By Nick Paul Taylor • Feb. 23, 2023 -
Medtronic boosts full-year outlook as supply challenges subside
The medical device maker said its cardiovascular and neuroscience units helped drive quarterly revenue growth.
By Susan Kelly • Feb. 21, 2023 -
Henry Schein Q4 profit drops, hurt by falling sales of COVID test kits, PPE
Flu and COVID-19 cases increased appointment cancellations and added to staffing shortages in the quarter.
By Nick Paul Taylor • Feb. 17, 2023 -
Labcorp expects 2023 revenue growth, helped by Ascension testing agreement
The company’s business model is shifting as the diagnostics firm prepares to spin off its drug development business and expands management of hospital testing labs.
By Elise Reuter • Feb. 16, 2023 -
Embecta raises 2023 earnings forecast after better-than-expected start
Almost a year after the company spun off from Becton Dickinson, CEO Dev Kurdikar said Embecta’s quarterly results “exceeded our initial expectations” in a challenging market.
By Elise Reuter • Feb. 15, 2023 -
Baxter to cut about 3,000 jobs after earnings slump on supply chain woes
The economic slowdown also hurt profit in the period even as the company posted double-digit sales growth.
By Nick Paul Taylor • Feb. 10, 2023 -
Dexcom reports another record year of new customers amid continued demand for G6 device
The diabetes tech firm aims to keep boosting awareness of its CGMs with another Super Bowl commercial.
By Elise Reuter • Feb. 9, 2023 -
Illumina posts sales slump in Q4, bets on new sequencing machine to drive 2023 growth
Management is looking to the newly launched NovaSeq X system to help return the company to profitability this year.
By Nick Paul Taylor • Feb. 8, 2023 -
Diagnostic firms turn to restructuring in bid to preserve cash: Goldman
The moves could lead to underfunding, delay or cancellation of research and development projects, the analysts say.
By Nick Paul Taylor • Feb. 7, 2023 -
Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023
Still, the latest round of quarterly results show that hospital staffing and supply chain remain a challenge.
By Nick Paul Taylor • Feb. 6, 2023 -
Zimmer Biomet Q4 net loss widens on supply problems; CEO targets acquisitions
The company plans to enter higher-growth markets, even outside of orthopedics, in a bid to increase revenue.
By Elise Reuter • Feb. 3, 2023 -
Quest cuts 2023 COVID tests forecast amid continued slump in demand; Q4 profit plunges
The company performed 1.2 million molecular tests in the fourth quarter, down from 1.9 million in the third quarter and 5.4 million one year ago.
By Nick Paul Taylor • Feb. 3, 2023 -
BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables
The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.
By Susan Kelly • Feb. 2, 2023 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes
Lower diagnostics revenue hurt sales in the three months ended Dec. 31.
By Nick Paul Taylor • Feb. 2, 2023 -
Boston Scientific gets Q4 boost from heart, urology sales
Following a series of significant acquisitions, the company said it expects net sales growth of about 5% to 7% in full-year 2023.
By Susan Kelly • Feb. 1, 2023 -
Edwards posts Q4 profit, reaffirms 2023 outlook as patients return
The heart valve specialist said it is optimistic that the healthcare environment will gradually improve this year.
By Susan Kelly • Feb. 1, 2023 -
Stryker expects 2023 growth despite 15% dip in Q4 net income
CEO Kevin Lobo said he expects new product launches and device orders will offset continued “macroeconomic volatility.”
By Elise Reuter • Feb. 1, 2023 -
GE HealthCare posts revenue growth in last quarter before spinoff on imaging, ultrasound units
The company benefitted from “robust end-market demand, improved pricing, and easing supply chain pressures” in the period.
By Peter Green • Jan. 30, 2023 -
ResMed quarterly revenue beats estimates as supply chain woes ease
Demand for CPAP devices and respirators remains strong as the company expects to pick up additional market share from rival Philips, and demand grows for its medical SaaS products.
By Susan Kelly • Jan. 27, 2023